This locus harbors multiple coronary artery disease (CAD) risk variants, including two functional variants reported to abrogate the function of an enhancer (ECAD9) by disrupting TEAD3 and STAT1 binding, thereby misregulating the expression of the target genes, CDKN2A/B (22, –24). The gene discussed is TEAD3; the disease is coronary artery disorder.